Biocatalysts Market
PUBLISHED: 2026 ID: SMRC42181
SHARE
SHARE

Biocatalysts Market

Biocatalysts Market Forecasts to 2034 – Global Analysis By Catalyst Type (Hydrolases, Oxidoreductases, Transferases, Lyases, Isomerases, Ligases and Other Catalyst Types), Source, Form, Process, Application, End User and By Geography

4.9 (76 reviews)
4.9 (76 reviews)
Published: 2026 ID: SMRC42181

Due to ongoing shifts in global trade and tariffs, the market outlook will be refreshed before delivery, including updated forecasts and quantified impact analysis. Recommendations and Conclusions will also be revised to offer strategic guidance for navigating the evolving international landscape.
Loading...
According to Stratistics MRC, the Global Biocatalysts Market is accounted for $0.68 billion in 2026 and is expected to reach $1.30 billion by 2034 growing at a CAGR of 8.4% during the forecast period. Biocatalysts are biological catalysts, typically enzymes or whole microbial cells, that accelerate chemical reactions under mild temperature, pressure, and pH conditions. These catalysts function through highly specific active sites that recognize and convert particular substrates, enabling selective transformations that are difficult to achieve through conventional chemistry. Biocatalysts are derived from bacterial, fungal, plant, and animal sources, and can be deployed as free enzymes, immobilized enzymes, or whole-cell systems. Their operational advantages include reduced energy consumption, minimized byproduct formation, and compatibility with aqueous reaction media, making them integral to pharmaceutical synthesis, food processing, biofuel production, and environmental remediation.

Market Dynamics:

Driver:

Accelerating Shift Toward Green Chemistry

The escalating regulatory pressure on hazardous solvents and energy-intensive chemical processes is compelling manufacturers to adopt biocatalytic alternatives across pharmaceutical, fine chemical, and food production. Biocatalysts operate under mild conditions that substantially reduce energy consumption and waste generation, while their high substrate specificity minimizes unwanted byproducts. As sustainability mandates tighten in Europe and North America, and as carbon pricing mechanisms expand, the commercial case for enzyme-mediated synthesis strengthens, thereby driving sustained investment in biocatalyst discovery and process integration.

Restraint:

High Development and Scale-Up Costs

The discovery, engineering, and optimization of proprietary enzymes demand specialized facilities, skilled personnel, and extensive iterative screening, often placing development costs beyond the reach of smaller manufacturers. Scale-up from laboratory to industrial volumes introduces additional technical hurdles, including enzyme stability under reactor conditions and batch-to-batch consistency requirements. These cost and complexity barriers slow adoption in cost-sensitive segments and geographic regions where capital access is constrained, limiting the pace at which biocatalysis displaces established chemical routes.

Opportunity:

AI-Accelerated Enzyme Engineering

Artificial intelligence platforms are dramatically compressing enzyme discovery and optimization timelines, enabling researchers to screen millions of protein sequences in silico before committing to wet-lab validation. AI-guided directed evolution has demonstrated the capacity to convert wild-type enzymes into industrial-grade biocatalysts within months rather than years, while simultaneously improving activity and stability. As these computational tools become more accessible and training datasets expand, the cost and risk of developing tailored biocatalysts decline, opening new application pathways in specialty chemical synthesis and emerging markets.

Threat:

Regulatory and Standardization Gaps

The absence of harmonized international standards for biocatalyst safety, efficacy assessment, and industrial deployment creates uncertainty for manufacturers seeking global market access. Divergent regulatory pathways across jurisdictions complicate product registration and lengthen commercialization timelines, particularly for novel enzymes intended for pharmaceutical or food-contact applications. In the absence of clear guidance, manufacturers may defer investment in next-generation biocatalyst platforms or restrict their market entry to regions with established regulatory frameworks, thereby constraining the sector's global growth trajectory.

Covid-19 Impact:

The pandemic disrupted enzyme supply chains and laboratory operations, delaying development timelines for industrial biocatalyst programs. Mid-pandemic, demand from pharmaceutical applications surged as vaccine and therapeutic manufacturing scaled rapidly, partially offsetting weakness in biofuels and textiles. Post-pandemic, the structural emphasis on supply chain resilience and domestic biomanufacturing capacity has durably accelerated investment in biocatalyst platforms, with governments in North America, Europe, and Asia Pacific prioritizing industrial biotechnology as a strategic capability.

The hydrolases segment is expected to be the largest during the forecast period

The hydrolases segment is expected to account for the largest market share during the forecast period, due to their broad substrate range and established deployment across food processing, detergents, textiles, and pharmaceutical synthesis. These enzymes catalyze bond cleavage reactions with water and benefit from mature production infrastructure and regulatory familiarity, which supports their continued dominance in volume terms. As industrial users seek to replace harsh chemical hydrolysis with enzymatic alternatives, the entrenched position of hydrolases across multiple end-user sectors reinforces their leading revenue contribution throughout the forecast horizon.

The immobilized enzymes segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the immobilized enzymes segment is predicted to witness the highest growth rate, driven by the operational requirement for enzyme recovery and reuse in continuous flow manufacturing. Immobilization enables repeated catalytic cycles, reduces enzyme consumption, and facilitates integration into fixed-bed reactor systems, which in turn improves process economics for pharmaceutical and fine chemical production. As continuous manufacturing adoption expands and immobilized enzyme formulations achieve greater stability and loading capacity, demand for these systems is expected to outpace free enzyme alternatives.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the concentration of leading biocatalyst producers, advanced biopharmaceutical manufacturing infrastructure, and substantial public and private investment in enzyme engineering research. The United States accounts for the majority of regional demand, supported by major industry participants including Novonesis, Codexis, and Thermo Fisher Scientific. Canada contributes through expanding biomanufacturing capacity, while Mexico offers growing opportunities in food processing and industrial enzyme applications, reinforcing the region's revenue leadership.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapid industrialization, expanding pharmaceutical and food production capacity, and supportive government policies promoting domestic biomanufacturing. China and India are investing heavily in enzyme production and industrial biotechnology infrastructure, while Japan and South Korea contribute advanced capabilities in specialty enzyme development. Growing demand for biofuels, animal feed enzymes, and sustainable chemical processes across Southeast Asia further accelerates regional growth, positioning Asia Pacific as the fastest-expanding market throughout the forecast period.

Key players in the market

Some of the key players in Biocatalysts Market include Novonesis A/S, BASF SE, Codexis, Inc., Amano Enzyme Inc., AB Enzymes GmbH, Advanced Enzyme Technologies Limited, Kerry Group plc, DSM-Firmenich AG, International Flavors & Fragrances Inc., Evonik Industries AG, Merck KGaA, Thermo Fisher Scientific Inc., Enzyme Development Corporation, Creative Enzymes, Biocatalysts Ltd., Dyadic International, Inc., Ginkgo Bioworks Holdings, Inc., and BRAIN Biotech AG.

Key Developments:

In November 2026, BRAIN Biotech AG entered a strategic collaboration with Syngenta to accelerate the development of next-generation biologicals, integrating its microbial strain engineering and enzyme expertise to support sustainable agricultural solutions.

In October 2026, HydRegen secured $8 million in Series A funding to deploy its enzyme-based hydrogenation platform across industrial chemical manufacturing, enabling drop-in replacement of precious-metal catalysts within existing plant infrastructure.

In September 2026, Enginzyme AB raised SEK 75 million to advance its commercial biomanufacturing strategy, accelerating deployment of its patented enzyme immobilization technology for cost-efficient production in personal care, food, and pharmaceutical applications.

In August 2026, Novonesis A/S expanded its enzyme portfolio with new solutions targeting lignocellulosic biomass conversion, enhancing biocatalyst performance for second-generation biofuel and biochemical production.

Catalyst Types Covered:
• Hydrolases
• Oxidoreductases
• Transferases
• Lyases
• Isomerases
• Ligases
• Other Catalyst Types

Sources Covered:
• Bacterial
• Fungal
• Plant-Derived
• Animal-Derived
• Other Sources

Forms Covered:
• Free Enzymes
• Immobilized Enzymes
• Whole-Cell Biocatalysts

Processes Covered:
• Hydrolysis
• Oxidation and Reduction
• Transesterification
• Synthesis and Resolution
• Isomerization
• Other Processes

Applications Covered:
• Active Pharmaceutical Ingredient Synthesis
• Chiral Intermediate Production
• Starch Hydrolysis and Sugar Conversion
• Protein Modification and Hydrolysis
• Lipid Modification and Esterification
• Lignocellulosic Biomass Conversion
• Textile Desizing and Biopolishing
• Pulp Bleaching and Fiber Modification
• Biodegradation and Pollutant Removal
• Other Applications

End Users Covered:
• Pharmaceutical and Biotechnology Companies
• Food and Beverage Manufacturers
• Chemical Manufacturers
• Biofuel and Biorefinery Operators
• Textile and Apparel Manufacturers
• Pulp and Paper Manufacturers
• Environmental Services Companies
• Agricultural and Animal Feed Producers
• Research Institutes and Academic Laboratories
• Other End Users

Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
 Saudi Arabia
 United Arab Emirates
 Qatar
 Israel
 Rest of Middle East
o Africa
 South Africa
 Egypt
 Morocco
 Rest of Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Biocatalysts Market, By Catalyst Type
5.1 Hydrolases
5.2 Oxidoreductases
5.3 Transferases
5.4 Lyases
5.5 Isomerases
5.6 Ligases
5.7 Other Catalyst Types

6 Global Biocatalysts Market, By Source
6.1 Bacterial
6.2 Fungal
6.3 Plant-Derived
6.4 Animal-Derived
6.5 Other Sources

7 Global Biocatalysts Market, By Form
7.1 Free Enzymes
7.2 Immobilized Enzymes
7.3 Whole-Cell Biocatalysts

8 Global Biocatalysts Market, By Process
8.1 Hydrolysis
8.2 Oxidation and Reduction
8.3 Transesterification
8.4 Synthesis and Resolution
8.5 Isomerization
8.6 Other Processes

9 Global Biocatalysts Market, By Application
9.1 Active Pharmaceutical Ingredient Synthesis
9.2 Chiral Intermediate Production
9.3 Starch Hydrolysis and Sugar Conversion
9.4 Protein Modification and Hydrolysis
9.5 Lipid Modification and Esterification
9.6 Lignocellulosic Biomass Conversion
9.7 Textile Desizing and Biopolishing
9.8 Pulp Bleaching and Fiber Modification
9.9 Biodegradation and Pollutant Removal
9.10 Other Applications

10 Global Biocatalysts Market, By End User
10.1 Pharmaceutical and Biotechnology Companies
10.2 Food and Beverage Manufacturers
10.3 Chemical Manufacturers
10.4 Biofuel and Biorefinery Operators
10.5 Textile and Apparel Manufacturers
10.6 Pulp and Paper Manufacturers
10.7 Environmental Services Companies
10.8 Agricultural and Animal Feed Producers
10.9 Research Institutes and Academic Laboratories
10.10 Other End Users

11 Global Biocatalysts Market, By Geography
11.1 North America
11.1.1 United States
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 United Kingdom
11.2.2 Germany
11.2.3 France
11.2.4 Italy
11.2.5 Spain
11.2.6 Netherlands
11.2.7 Belgium
11.2.8 Sweden
11.2.9 Switzerland
11.2.10 Poland
11.2.11 Rest of Europe
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Australia
11.3.6 Indonesia
11.3.7 Thailand
11.3.8 Malaysia
11.3.9 Singapore
11.3.10 Vietnam
11.3.11 Rest of Asia Pacific
11.4 South America
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Colombia
11.4.4 Chile
11.4.5 Peru
11.4.6 Rest of South America
11.5 Rest of the World (RoW)
11.5.1 Middle East
11.5.1.1 Saudi Arabia
11.5.1.2 United Arab Emirates
11.5.1.3 Qatar
11.5.1.4 Israel
11.5.1.5 Rest of Middle East
11.5.2 Africa
11.5.2.1 South Africa
11.5.2.2 Egypt
11.5.2.3 Morocco
11.5.2.4 Rest of Africa

12 Strategic Market Intelligence
12.1 Industry Value Network and Supply Chain Assessment
12.2 White-Space and Opportunity Mapping
12.3 Product Evolution and Market Life Cycle Analysis
12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives
13.1 Mergers and Acquisitions
13.2 Partnerships, Alliances, and Joint Ventures
13.3 New Product Launches and Certifications
13.4 Capacity Expansion and Investments
13.5 Other Strategic Initiatives

14 Company Profiles
14.1 Novonesis A/S
14.2 BASF SE
14.3 Codexis, Inc.
14.4 Amano Enzyme Inc.
14.5 AB Enzymes GmbH
14.6 Advanced Enzyme Technologies Limited
14.7 Kerry Group plc
14.8 DSM-Firmenich AG
14.9 International Flavors & Fragrances Inc.
14.10 Evonik Industries AG
14.11 Merck KGaA
14.12 Thermo Fisher Scientific Inc.
14.13 Enzyme Development Corporation
14.14 Creative Enzymes
14.15 Biocatalysts Ltd.
14.16 Dyadic International, Inc.
14.17 Ginkgo Bioworks Holdings, Inc.
14.18 BRAIN Biotech AG

List of Tables
1 Global Biocatalysts Market Outlook, By Region (2023-2034) ($MN)
2 Global Biocatalysts Market Outlook, By Catalyst Type (2023-2034) ($MN)
3 Global Biocatalysts Market Outlook, By Hydrolases (2023-2034) ($MN)
4 Global Biocatalysts Market Outlook, By Oxidoreductases (2023-2034) ($MN)
5 Global Biocatalysts Market Outlook, By Transferases (2023-2034) ($MN)
6 Global Biocatalysts Market Outlook, By Lyases (2023-2034) ($MN)
7 Global Biocatalysts Market Outlook, By Isomerases (2023-2034) ($MN)
8 Global Biocatalysts Market Outlook, By Ligases (2023-2034) ($MN)
9 Global Biocatalysts Market Outlook, By Other Catalyst Types (2023-2034) ($MN)
10 Global Biocatalysts Market Outlook, By Source (2023-2034) ($MN)
11 Global Biocatalysts Market Outlook, By Bacterial (2023-2034) ($MN)
12 Global Biocatalysts Market Outlook, By Fungal (2023-2034) ($MN)
13 Global Biocatalysts Market Outlook, By Plant-Derived (2023-2034) ($MN)
14 Global Biocatalysts Market Outlook, By Animal-Derived (2023-2034) ($MN)
15 Global Biocatalysts Market Outlook, By Other Sources (2023-2034) ($MN)
16 Global Biocatalysts Market Outlook, By Form (2023-2034) ($MN)
17 Global Biocatalysts Market Outlook, By Free Enzymes (2023-2034) ($MN)
18 Global Biocatalysts Market Outlook, By Immobilized Enzymes (2023-2034) ($MN)
19 Global Biocatalysts Market Outlook, By Whole-Cell Biocatalysts (2023-2034) ($MN)
20 Global Biocatalysts Market Outlook, By Process (2023-2034) ($MN)
21 Global Biocatalysts Market Outlook, By Hydrolysis (2023-2034) ($MN)
22 Global Biocatalysts Market Outlook, By Oxidation and Reduction (2023-2034) ($MN)
23 Global Biocatalysts Market Outlook, By Transesterification (2023-2034) ($MN)
24 Global Biocatalysts Market Outlook, By Synthesis and Resolution (2023-2034) ($MN)
25 Global Biocatalysts Market Outlook, By Isomerization (2023-2034) ($MN)
26 Global Biocatalysts Market Outlook, By Other Processes (2023-2034) ($MN)
27 Global Biocatalysts Market Outlook, By Application (2023-2034) ($MN)
28 Global Biocatalysts Market Outlook, By Active Pharmaceutical Ingredient Synthesis (2023-2034) ($MN)
29 Global Biocatalysts Market Outlook, By Chiral Intermediate Production (2023-2034) ($MN)
30 Global Biocatalysts Market Outlook, By Starch Hydrolysis and Sugar Conversion (2023-2034) ($MN)
31 Global Biocatalysts Market Outlook, By Protein Modification and Hydrolysis (2023-2034) ($MN)
32 Global Biocatalysts Market Outlook, By Lipid Modification and Esterification (2023-2034) ($MN)
33 Global Biocatalysts Market Outlook, By Lignocellulosic Biomass Conversion (2023-2034) ($MN)
34 Global Biocatalysts Market Outlook, By Textile Desizing and Biopolishing (2023-2034) ($MN)
35 Global Biocatalysts Market Outlook, By Pulp Bleaching and Fiber Modification (2023-2034) ($MN)
36 Global Biocatalysts Market Outlook, By Biodegradation and Pollutant Removal (2023-2034) ($MN)
37 Global Biocatalysts Market Outlook, By Other Applications (2023-2034) ($MN)
38 Global Biocatalysts Market Outlook, By End User (2023-2034) ($MN)
39 Global Biocatalysts Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
40 Global Biocatalysts Market Outlook, By Food and Beverage Manufacturers (2023-2034) ($MN)
41 Global Biocatalysts Market Outlook, By Chemical Manufacturers (2023-2034) ($MN)
42 Global Biocatalysts Market Outlook, By Biofuel and Biorefinery Operators (2023-2034) ($MN)
43 Global Biocatalysts Market Outlook, By Textile and Apparel Manufacturers (2023-2034) ($MN)
44 Global Biocatalysts Market Outlook, By Pulp and Paper Manufacturers (2023-2034) ($MN)
45 Global Biocatalysts Market Outlook, By Environmental Services Companies (2023-2034) ($MN)
46 Global Biocatalysts Market Outlook, By Agricultural and Animal Feed Producers (2023-2034) ($MN)
47 Global Biocatalysts Market Outlook, By Research Institutes and Academic Laboratories (2023-2034) ($MN)
48 Global Biocatalysts Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We offer complimentary customization of up to 15% with every purchase.

To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .

Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials